Facilitating strong and equitable partnerships between academia, industry and the NHS - along with promoting effective engagement with regulators and policy makers - is a major focus of the Academy’s activities.
We seek to capitalise on our independence and ability to connect stakeholders from across the life sciences sector to meet this objective.
To promote sustainable translation of research outputs into health and wealth gains, we will explore new models of: regulating and governing health research that keep pace with scientific and technological developments in fields such as regenerative medicine; valuing and rewarding innovation; and partnerships and funding in the discovery and development pipeline of medical innovations.
Addressing new health, scientific and economic challenges involves drawing on strengths from across sectors and requires organisations to collaborate to share expertise, skills and resources within a strong and vibrant innovation ecosystem.
Strong links between academia, industry and the NHS - which acts as a driver and adopter of research and innovation - are fundamental to this. We will continue to foster and support such links through our policy work and networking activities including the FORUM.
We aim to foster an environment that attracts and retains pharmaceutical companies in the UK; supports home-grown biotechnology and medical device companies; and encourages entrepreneurs and investors to establish new enterprises.
We undertake a range of activities in support of this, including: engagement with government through our statements/position papers and consultation responses; work to streamline the regulation and governance of health research; and promoting the value of industry as a place for employment, secondment or collaboration. We are also working with the Learned Societies to retain and enhance drug discovery capabilities in the UK.
The Academy’s FORUM provides a neutral and independent platform for individuals from across academia, industry, government, and the charity, healthcare and regulatory sectors to meet and take forward national discussions on scientific opportunities, technology trends and associated strategic choices for healthcare and other life sciences sectors.